Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. WOK
WOK logo

WOK Overview

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Loading chart...

High
5.740
Open
5.690
VWAP
3.57
Vol
10.52M
Mkt Cap
147.80K
Low
1.780
Amount
37.58M
EV/EBITDA(TTM)
--
Total Shares
1.72M
EV
12.87M
EV/OCF(TTM)
2.06
P/S(TTM)
0.00
Work Medical Technology Group Ltd is a holding company mainly engaged in the manufacturing of medical devices. The Company's main products include medical face masks, artery compression tourniquets, endotracheal tube holders, intubating stylets, guedel airways, and other Class I disposable medical devices, disposable breathing circuits, laryngeal mask airways, endotracheal tubes, anesthetic kit, oxygen face masks, anesthesia masks, laryngoscope blades, yankauer suction sets, nasal oxygen cannulas, and other Class II disposable medical devices, KN95 masks, filtering half mask, and other medical devices, as well as medical innovative devices and equipment, such as visualized prostatic dilatation catheter. The Company principally conducts its businesses in domestic and overseas markets, such as Asia, Africa, Europe, North America, South America, and Oceania.
Show More

Events Timeline

(ET)
2026-06-17
20:00:00
Work Medical Technology Group Ltd Trading Halted, News Pending
select
2026-05-13 (ET)
2026-05-13
09:40:00
Work Medical Technology Group Ltd Trading Halted
select
2026-05-11 (ET)
2026-05-11
09:40:00
WORK Medical Enters Strategic Cooperation Agreement with Novabioplus
select
2025-12-29 (ET)
2025-12-29
09:40:00
WORK Medical Technology Signs Exclusive Distribution Agreement with Shanghai Benke
select
2025-12-29
09:10:00
WORK Medical Technology Subsidiary Receives Approval for AI Blood Cell Analyzer
select
2025-12-26 (ET)
2025-12-26
20:00:00
Work Medical Technology Group Ltd Trading Halted, News Pending
select
2025-12-10 (ET)
2025-12-10
09:40:00
Work Medical Technology Group Ltd Trading Resumes
select
2025-12-10
09:40:00
Work Medical Technology Group Ltd Trading Halted Due to Volatility
select

News

seekingalpha
8.5
06-16seekingalpha
WORK Medical Technology Group Announces 1-for-100 Reverse Stock Split
  • Reverse Stock Split Announcement: WORK Medical Technology Group has announced a 1-for-100 reverse stock split effective June 18, 2026, which is expected to reduce the outstanding Class A shares from 241.65 million to approximately 2.42 million, aimed at increasing the stock price to attract more investors.
  • Shareholder Rights Adjustment: Under the transaction terms, shares held through banks, brokers, and other nominees will be automatically adjusted, ensuring that all shareholders maintain their proportional ownership, thereby preserving the stability and transparency of shareholder rights.
  • Positive Market Reaction: Following the announcement of the reverse stock split, WORK Medical Technology Group's stock price surged by 13.81%, indicating increased market confidence in the company's future prospects, which may attract more institutional investors.
  • Strategic Implications: This reverse stock split not only aims to improve the company's stock performance but also enhances its image in the capital markets, potentially increasing its competitiveness and appeal in the medical technology sector.
Newsfilter
7.5
06-05Newsfilter
WORK Medical Engages at 2026 CBA Conference
  • Global Collaboration Opportunities: At the 2026 CBA Conference, WORK Medical engaged with industry experts from North America, Europe, and the Asia-Pacific region to discuss global supply chain collaboration and the application of AI in life sciences, aiming to foster future cross-border partnerships and technology development through these interactions.
  • Strategic Positioning Showcase: The company not only showcased its medical hardware and consumables business but also emphasized its strategic positioning in the 'AI+Digital Healthcare' sector, indicating a continued transformation in data enablement and digital asset operations, which is expected to attract high-value strategic partners.
  • International Network Expansion: By participating in this conference, WORK Medical aims to strengthen its connections with the global biopharmaceutical community, enhancing its presence within international professional networks to support future innovation initiatives and provide insights into emerging clinical needs.
  • Management Commentary: CEO Wu Shuang stated that the CBA Conference serves as an important platform connecting China's biopharmaceutical sector with the global scientific community, and WORK Medical will continue to deepen relationships with industry leaders through participation in international events to advance its globalization strategy.
stocktwits
4.0
05-13stocktwits
Oil Prices Surge as Markets Eye Trump-Xi Summit
  • Oil Price Surge: Brent crude prices are nearing $107 per barrel and WTI above $102, having risen nearly 8% over the past three sessions, which pressures market sentiment, particularly following Trump's criticism of the U.S.-Iran ceasefire agreement.
  • Market Reaction: U.S. stock futures edged higher late Tuesday, with Nasdaq 100 futures up 0.2% and S&P 500 futures gaining 0.1%, while Dow futures dipped slightly, reflecting investor caution ahead of key inflation data.
  • Trump-Xi Summit: The anticipated summit between Trump and Xi on May 14-15 is expected to focus on trade negotiations despite ongoing tensions in Iran, with markets hopeful for outcomes that could stabilize oil prices and enhance trade relations, given China's significant oil imports from Iran.
  • Economic Indicators Watch: Markets are closely monitoring the upcoming producer price index (PPI) report, with expectations for a 0.5% month-over-month increase in April's PPI and a 0.3% rise in core PPI, which could influence the Federal Reserve's monetary policy direction.
stocktwits
7.5
05-13stocktwits
Work Medical Partners with Novabioplus for AI Healthcare Systems
  • Stock Surge: Work Medical (WOK) shares skyrocketed nearly 300% this week, with a 200% increase on Monday following the announcement of its AI biotech partnership with Shanghai Novabioplus, and a further 70% rise on Tuesday, reflecting strong market enthusiasm for its new strategic direction.
  • AI Project Collaboration: The partnership includes four major AI-focused projects involving protein design, antibody optimization, enzyme engineering, and peptide development, aimed at accelerating drug discovery and enhancing biotech R&D efficiency by leveraging both companies' technologies and datasets.
  • BioToken Concept: Work Medical introduced the “BioToken” concept, planning to integrate biological data with blockchain to create digital biological assets, which is expected to drive the digitization and assetization of biopharmaceutical research outputs, enhancing its competitive edge in the market.
  • Deepening Web3 Strategy: The company continues to advance its blockchain and asset tokenization strategy, recently receiving a Vice President Unit certificate from the Hong Kong Web3.0 Standardization Association, indicating its leadership role in building digital infrastructure for medical assets.
Newsfilter
2.0
05-11Newsfilter
WORK Medical Partners with Novabioplus for AI-Driven Healthcare Innovation
  • Strategic Cooperation Agreement: WORK Medical signed a strategic cooperation agreement with Novabioplus on April 13, 2026, aiming to jointly develop next-generation intelligent medical models that integrate WORK Medical's AI-driven healthcare digital transformation with Novabioplus' protein data resources, thereby enhancing the latent value of biological data assets.
  • AI-Driven Product Development: Under the agreement, the parties will combine WORK Medical's AI algorithms with Novabioplus' protein datasets to advance the R&D of AI-driven protein antibody therapeutics, which is expected to accelerate innovation and application in the biopharmaceutical sector.
  • BioToken Model Development: The collaboration will generate
Newsfilter
7.5
05-01Newsfilter
WORK Medical Recognized as Vice President Unit of Hong Kong Web3.0 Association
  • Industry Leadership: WORK Medical has been awarded the Vice President Unit certification by the Hong Kong Web3.0 Standardization Association, underscoring its growing leadership in the tokenization of medical assets and data, which is expected to enhance the company's influence in the digital healthcare economy.
  • Whitepaper Release: At the Web3.0 Standardization and Globalization Summit in Hong Kong, WORK Medical released the Asset Tokenization Whitepaper, which provides a structured framework for global standardization at the intersection of medical devices and Web3.0, highlighting the company's significant role in industry standard development.
  • Advancement of A2A Payments: The company is advancing the implementation of A2A autonomous payment protocols aimed at enabling cross-border value exchange through stablecoins, which is expected to improve transaction efficiency and reduce liquidity costs for medical assets, facilitating their digital transformation.
  • Strategic Transformation: Management stated that WORK Medical is transforming from a traditional supplier of medical consumables to a builder of next-generation medical infrastructure, focusing on leveraging AI and blockchain technology to drive a sustainable healthcare economy and create long-term digital value.

Valuation Metrics

The current forward P/E ratio for WORK Medical Technology Group Ltd (WOK.O) is 0.00, compared to its 5-year average forward P/E of 0.00. For a more detailed relative valuation and DCF analysis to assess WORK Medical Technology Group Ltd's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
0.00
Current PE
0.00
Overvalued PE
0.00
Undervalued PE
0.00

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
0.00
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
0.00
Undervalued EV/EBITDA
0.00

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PS
0.00
Current PS
0.00
Overvalued PS
0.00
Undervalued PS
0.00

Financials

AI Analysis
Annual
Quarterly

Related Community Screener

ARE QUANTUM STOCKS GOING DOWN
Intellectia · 29 candidates
Rsi Category: moderateRelative Vol: >= 1.50Moving Average Relationship: PriceBelowMA20, PriceBelowMA200Month Price Change Pct: <= $0.00Ema 20: >= -100Ema 60: >= -100Monthly Average Dollar Volume: >= 1,000,000Macd: bearish
Ticker
Name
Market Cap$
top bottom
WOK logo
WOK
WORK Medical Technology Group Ltd
191.43K
LICN logo
LICN
Lichen International Ltd
17.75M
ZEPP logo
ZEPP
Zepp Health Corp
129.05M
FUTU logo
FUTU
Futu Holdings Ltd
15.10B
TIGR logo
TIGR
UP Fintech Holding Ltd
894.39M
CRBP logo
CRBP
Corbus Pharmaceuticals Holdings Inc
210.29M
what are the highest volume nasdaq stocks
Intellectia · 5293 candidates
Ticker
Name
Market Cap$
top bottom
LIMN logo
LIMN
Liminatus Pharma Inc
8.43M
SBFM logo
SBFM
Sunshine Biopharma Inc
2.55M
NVDA logo
NVDA
NVIDIA Corp
5.41T
RGTI logo
RGTI
Rigetti Computing Inc
5.61B
NCPL logo
NCPL
Netcapital Inc
3.56M
WOK logo
WOK
WORK Medical Technology Group Ltd
11.49M
what stocks are falling today
Intellectia · 2580 candidates
Price Change Pct: <= $0.00
Ticker
Name
Market Cap$
top bottom
BTM logo
BTM
Bitcoin Depot Inc
32.61M
LICN logo
LICN
Lichen International Ltd
137.90M
GOSS logo
GOSS
Gossamer Bio Inc
79.80M
WOK logo
WOK
WORK Medical Technology Group Ltd
11.49M
YOOV logo
YOOV
Concorde International Group Ltd
290.54M
NEOV logo
NEOV
NeoVolta Inc
109.34M
stocks that will explode in next 30 days
Intellectia · 640 candidates
Relative Vol: >= 1.50Moving Average Relationship: PriceAboveMA5, PriceAboveMA20Month Price Change Pct: >= $0.00One Month Rise Prob: >= 70One Month Predict Return: >= 0.0%
Ticker
Name
Market Cap$
top bottom
PRCH logo
PRCH
Porch Group Inc
1.23B
ROMA logo
ROMA
Roma Green Finance Ltd
396.70M
MCBS logo
MCBS
Metrocity Bankshares Inc
921.13M
UA logo
UA
Under Armour Inc
2.59B
INNV logo
INNV
InnovAge Holding Corp
1.08B
DOCN logo
DOCN
DigitalOcean Holdings Inc
15.94B
stock bullish for a month
Intellectia · 644 candidates
Relative Vol: >= 1.50Moving Average Relationship: PriceAboveMA20, PriceAboveMA200Month Price Change Pct: >= $0.00Ema 20: >= 0Ema 60: >= 0One Month Rise Prob: >= 70One Month Predict Return: >= 0.0%
Ticker
Name
Market Cap$
top bottom
WOK logo
WOK
WORK Medical Technology Group Ltd
2.40M
SABS logo
SABS
SAB Biotherapeutics Inc
258.61M
GIII logo
GIII
G-III Apparel Group Ltd
1.31B
IRIX logo
IRIX
IRIDEX Corp
18.27M
CCO logo
CCO
Clear Channel Outdoor Holdings Inc
1.19B
VTMX logo
VTMX
Vesta Real Estate Corporation SAB de CV
3.03B

Whales Holding WOK

Trading Trends

    Insider
    Hedge Fund
    Congress Trading

People Also Watch

Frequently Asked Questions

What is WORK Medical Technology Group Ltd (WOK) stock price today?

The current price of WOK is 3.2 USD — it has decreased -25.93

What is WORK Medical Technology Group Ltd (WOK)'s business?

Work Medical Technology Group Ltd is a holding company mainly engaged in the manufacturing of medical devices. The Company's main products include medical face masks, artery compression tourniquets, endotracheal tube holders, intubating stylets, guedel airways, and other Class I disposable medical devices, disposable breathing circuits, laryngeal mask airways, endotracheal tubes, anesthetic kit, oxygen face masks, anesthesia masks, laryngoscope blades, yankauer suction sets, nasal oxygen cannulas, and other Class II disposable medical devices, KN95 masks, filtering half mask, and other medical devices, as well as medical innovative devices and equipment, such as visualized prostatic dilatation catheter. The Company principally conducts its businesses in domestic and overseas markets, such as Asia, Africa, Europe, North America, South America, and Oceania.

What is the price predicton of WOK Stock?

Wall Street analysts forecast WOK stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for WOK is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is WORK Medical Technology Group Ltd (WOK)'s revenue for the last quarter?

WORK Medical Technology Group Ltd revenue for the last quarter amounts to NaN USD, decreased

What is WORK Medical Technology Group Ltd (WOK)'s earnings per share (EPS) for the last quarter?

WORK Medical Technology Group Ltd. EPS for the last quarter amounts to USD, decreased

How many employees does WORK Medical Technology Group Ltd (WOK). have?

WORK Medical Technology Group Ltd (WOK) has 238 emplpoyees as of June 20 2026.

What is WORK Medical Technology Group Ltd (WOK) market cap?

Today WOK has the market capitalization of 147.80K USD.